Cohen's SAC Capital Discloses 5.7% Stake in Keryx Biopharmaceuticals (KERX)
Tweet Send to a Friend
In a 13G filing after the close on Keryx Biopharmaceuticals Inc. (Nasdaq: KERX), SAC Capital / Steven A. Cohen disclosed ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
